ODTX ▼ -0.6% - Odyssey Therapeutics, Inc.
$ODTX - Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
06-OCT-2026 08:01 AM ET
Share this post
More filings for $ODTX
ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.Oct 20, 2026ODTX ▼ -2.0% - Odyssey Therapeutics, Inc.Oct 20, 2026ODTX ▼ -0.3% - Odyssey Therapeutics, Inc.Oct 12, 2026ODTX ▼ -2.7% - Odyssey Therapeutics, Inc.Sep 16, 2026
View full $ODTX filing history →💬 Comments
Loading comments…
Leave a comment